Global Non-prescription Drugs Market Research Report 2024, Forecast to 2032
Report Overview
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Non-prescription Drugs market size was estimated at USD 125150 million in 2023 and is projected to reach USD 202629.65 million by 2032, exhibiting a CAGR of 5.50% during the forecast period.
North America Non-prescription Drugs market size was estimated at USD 35757.70 million in 2023, at a CAGR of 4.71% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Non-prescription Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-prescription Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-prescription Drugs market in any manner.
Global Non-prescription Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Market Segmentation (by Type)
Brand Drugs
Generic Drug
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-prescription Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-prescription Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
The global Non-prescription Drugs market size was estimated at USD 125150 million in 2023 and is projected to reach USD 202629.65 million by 2032, exhibiting a CAGR of 5.50% during the forecast period.
North America Non-prescription Drugs market size was estimated at USD 35757.70 million in 2023, at a CAGR of 4.71% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Non-prescription Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-prescription Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-prescription Drugs market in any manner.
Global Non-prescription Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Market Segmentation (by Type)
Brand Drugs
Generic Drug
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-prescription Drugs Market
- Overview of the regional outlook of the Non-prescription Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-prescription Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-prescription Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-prescription Drugs
1.2 Key Market Segments
1.2.1 Non-prescription Drugs Segment by Type
1.2.2 Non-prescription Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-PRESCRIPTION DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-prescription Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Non-prescription Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-PRESCRIPTION DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-prescription Drugs Sales by Manufacturers (2019-2024)
3.2 Global Non-prescription Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-prescription Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-prescription Drugs Sales Sites, Area Served, Product Type
3.6 Non-prescription Drugs Market Competitive Situation and Trends
3.6.1 Non-prescription Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-prescription Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-PRESCRIPTION DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Non-prescription Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-PRESCRIPTION DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-PRESCRIPTION DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-prescription Drugs Sales Market Share by Type (2019-2024)
6.3 Global Non-prescription Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Non-prescription Drugs Price by Type (2019-2024)
7 NON-PRESCRIPTION DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-prescription Drugs Market Sales by Application (2019-2024)
7.3 Global Non-prescription Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Non-prescription Drugs Sales Growth Rate by Application (2019-2024)
8 NON-PRESCRIPTION DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Non-prescription Drugs Sales by Region
8.1.1 Global Non-prescription Drugs Sales by Region
8.1.2 Global Non-prescription Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Non-prescription Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-prescription Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-prescription Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-prescription Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-prescription Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 NON-PRESCRIPTION DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Non-prescription Drugs by Region (2019-2024)
9.2 Global Non-prescription Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Non-prescription Drugs Production
9.4.1 North America Non-prescription Drugs Production Growth Rate (2019-2024)
9.4.2 North America Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Non-prescription Drugs Production
9.5.1 Europe Non-prescription Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Non-prescription Drugs Production (2019-2024)
9.6.1 Japan Non-prescription Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Non-prescription Drugs Production (2019-2024)
9.7.1 China Non-prescription Drugs Production Growth Rate (2019-2024)
9.7.2 China Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Non-prescription Drugs Basic Information
10.1.2 Pfizer Non-prescription Drugs Product Overview
10.1.3 Pfizer Non-prescription Drugs Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Non-prescription Drugs SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Roche
10.2.1 Roche Non-prescription Drugs Basic Information
10.2.2 Roche Non-prescription Drugs Product Overview
10.2.3 Roche Non-prescription Drugs Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Non-prescription Drugs SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Sanofi
10.3.1 Sanofi Non-prescription Drugs Basic Information
10.3.2 Sanofi Non-prescription Drugs Product Overview
10.3.3 Sanofi Non-prescription Drugs Product Market Performance
10.3.4 Sanofi Non-prescription Drugs SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Non-prescription Drugs Basic Information
10.4.2 Johnson and Johnson Non-prescription Drugs Product Overview
10.4.3 Johnson and Johnson Non-prescription Drugs Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Merck and Co. (MSD)
10.5.1 Merck and Co. (MSD) Non-prescription Drugs Basic Information
10.5.2 Merck and Co. (MSD) Non-prescription Drugs Product Overview
10.5.3 Merck and Co. (MSD) Non-prescription Drugs Product Market Performance
10.5.4 Merck and Co. (MSD) Business Overview
10.5.5 Merck and Co. (MSD) Recent Developments
10.6 Novartis
10.6.1 Novartis Non-prescription Drugs Basic Information
10.6.2 Novartis Non-prescription Drugs Product Overview
10.6.3 Novartis Non-prescription Drugs Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 AbbVie
10.7.1 AbbVie Non-prescription Drugs Basic Information
10.7.2 AbbVie Non-prescription Drugs Product Overview
10.7.3 AbbVie Non-prescription Drugs Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Non-prescription Drugs Basic Information
10.8.2 Gilead Sciences Non-prescription Drugs Product Overview
10.8.3 Gilead Sciences Non-prescription Drugs Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Non-prescription Drugs Basic Information
10.9.2 GlaxoSmithKline (GSK) Non-prescription Drugs Product Overview
10.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Amgen
10.10.1 Amgen Non-prescription Drugs Basic Information
10.10.2 Amgen Non-prescription Drugs Product Overview
10.10.3 Amgen Non-prescription Drugs Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Non-prescription Drugs Basic Information
10.11.2 AstraZeneca Non-prescription Drugs Product Overview
10.11.3 AstraZeneca Non-prescription Drugs Product Market Performance
10.11.4 AstraZeneca Business Overview
10.11.5 AstraZeneca Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Non-prescription Drugs Basic Information
10.12.2 Bristol-Myers Squibb Non-prescription Drugs Product Overview
10.12.3 Bristol-Myers Squibb Non-prescription Drugs Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Non-prescription Drugs Basic Information
10.13.2 Eli Lilly Non-prescription Drugs Product Overview
10.13.3 Eli Lilly Non-prescription Drugs Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Teva
10.14.1 Teva Non-prescription Drugs Basic Information
10.14.2 Teva Non-prescription Drugs Product Overview
10.14.3 Teva Non-prescription Drugs Product Market Performance
10.14.4 Teva Business Overview
10.14.5 Teva Recent Developments
10.15 Bayer
10.15.1 Bayer Non-prescription Drugs Basic Information
10.15.2 Bayer Non-prescription Drugs Product Overview
10.15.3 Bayer Non-prescription Drugs Product Market Performance
10.15.4 Bayer Business Overview
10.15.5 Bayer Recent Developments
10.16 Novo Nordisk
10.16.1 Novo Nordisk Non-prescription Drugs Basic Information
10.16.2 Novo Nordisk Non-prescription Drugs Product Overview
10.16.3 Novo Nordisk Non-prescription Drugs Product Market Performance
10.16.4 Novo Nordisk Business Overview
10.16.5 Novo Nordisk Recent Developments
10.17 AbbVie
10.17.1 AbbVie Non-prescription Drugs Basic Information
10.17.2 AbbVie Non-prescription Drugs Product Overview
10.17.3 AbbVie Non-prescription Drugs Product Market Performance
10.17.4 AbbVie Business Overview
10.17.5 AbbVie Recent Developments
10.18 Takeda
10.18.1 Takeda Non-prescription Drugs Basic Information
10.18.2 Takeda Non-prescription Drugs Product Overview
10.18.3 Takeda Non-prescription Drugs Product Market Performance
10.18.4 Takeda Business Overview
10.18.5 Takeda Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Non-prescription Drugs Basic Information
10.19.2 Boehringer Ingelheim Non-prescription Drugs Product Overview
10.19.3 Boehringer Ingelheim Non-prescription Drugs Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Takeda
10.20.1 Takeda Non-prescription Drugs Basic Information
10.20.2 Takeda Non-prescription Drugs Product Overview
10.20.3 Takeda Non-prescription Drugs Product Market Performance
10.20.4 Takeda Business Overview
10.20.5 Takeda Recent Developments
11 NON-PRESCRIPTION DRUGS MARKET FORECAST BY REGION
11.1 Global Non-prescription Drugs Market Size Forecast
11.2 Global Non-prescription Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-prescription Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Non-prescription Drugs Market Size Forecast by Region
11.2.4 South America Non-prescription Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Non-prescription Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Non-prescription Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Non-prescription Drugs by Type (2025-2032)
12.1.2 Global Non-prescription Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Non-prescription Drugs by Type (2025-2032)
12.2 Global Non-prescription Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Non-prescription Drugs Sales (K MT) Forecast by Application
12.2.2 Global Non-prescription Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-prescription Drugs
1.2 Key Market Segments
1.2.1 Non-prescription Drugs Segment by Type
1.2.2 Non-prescription Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-PRESCRIPTION DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-prescription Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Non-prescription Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-PRESCRIPTION DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Non-prescription Drugs Sales by Manufacturers (2019-2024)
3.2 Global Non-prescription Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-prescription Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-prescription Drugs Sales Sites, Area Served, Product Type
3.6 Non-prescription Drugs Market Competitive Situation and Trends
3.6.1 Non-prescription Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-prescription Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-PRESCRIPTION DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Non-prescription Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-PRESCRIPTION DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NON-PRESCRIPTION DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-prescription Drugs Sales Market Share by Type (2019-2024)
6.3 Global Non-prescription Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Non-prescription Drugs Price by Type (2019-2024)
7 NON-PRESCRIPTION DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-prescription Drugs Market Sales by Application (2019-2024)
7.3 Global Non-prescription Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Non-prescription Drugs Sales Growth Rate by Application (2019-2024)
8 NON-PRESCRIPTION DRUGS MARKET CONSUMPTION BY REGION
8.1 Global Non-prescription Drugs Sales by Region
8.1.1 Global Non-prescription Drugs Sales by Region
8.1.2 Global Non-prescription Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Non-prescription Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-prescription Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-prescription Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-prescription Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-prescription Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 NON-PRESCRIPTION DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Non-prescription Drugs by Region (2019-2024)
9.2 Global Non-prescription Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Non-prescription Drugs Production
9.4.1 North America Non-prescription Drugs Production Growth Rate (2019-2024)
9.4.2 North America Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Non-prescription Drugs Production
9.5.1 Europe Non-prescription Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Non-prescription Drugs Production (2019-2024)
9.6.1 Japan Non-prescription Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Non-prescription Drugs Production (2019-2024)
9.7.1 China Non-prescription Drugs Production Growth Rate (2019-2024)
9.7.2 China Non-prescription Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Pfizer
10.1.1 Pfizer Non-prescription Drugs Basic Information
10.1.2 Pfizer Non-prescription Drugs Product Overview
10.1.3 Pfizer Non-prescription Drugs Product Market Performance
10.1.4 Pfizer Business Overview
10.1.5 Pfizer Non-prescription Drugs SWOT Analysis
10.1.6 Pfizer Recent Developments
10.2 Roche
10.2.1 Roche Non-prescription Drugs Basic Information
10.2.2 Roche Non-prescription Drugs Product Overview
10.2.3 Roche Non-prescription Drugs Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche Non-prescription Drugs SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Sanofi
10.3.1 Sanofi Non-prescription Drugs Basic Information
10.3.2 Sanofi Non-prescription Drugs Product Overview
10.3.3 Sanofi Non-prescription Drugs Product Market Performance
10.3.4 Sanofi Non-prescription Drugs SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Non-prescription Drugs Basic Information
10.4.2 Johnson and Johnson Non-prescription Drugs Product Overview
10.4.3 Johnson and Johnson Non-prescription Drugs Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Merck and Co. (MSD)
10.5.1 Merck and Co. (MSD) Non-prescription Drugs Basic Information
10.5.2 Merck and Co. (MSD) Non-prescription Drugs Product Overview
10.5.3 Merck and Co. (MSD) Non-prescription Drugs Product Market Performance
10.5.4 Merck and Co. (MSD) Business Overview
10.5.5 Merck and Co. (MSD) Recent Developments
10.6 Novartis
10.6.1 Novartis Non-prescription Drugs Basic Information
10.6.2 Novartis Non-prescription Drugs Product Overview
10.6.3 Novartis Non-prescription Drugs Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 AbbVie
10.7.1 AbbVie Non-prescription Drugs Basic Information
10.7.2 AbbVie Non-prescription Drugs Product Overview
10.7.3 AbbVie Non-prescription Drugs Product Market Performance
10.7.4 AbbVie Business Overview
10.7.5 AbbVie Recent Developments
10.8 Gilead Sciences
10.8.1 Gilead Sciences Non-prescription Drugs Basic Information
10.8.2 Gilead Sciences Non-prescription Drugs Product Overview
10.8.3 Gilead Sciences Non-prescription Drugs Product Market Performance
10.8.4 Gilead Sciences Business Overview
10.8.5 Gilead Sciences Recent Developments
10.9 GlaxoSmithKline (GSK)
10.9.1 GlaxoSmithKline (GSK) Non-prescription Drugs Basic Information
10.9.2 GlaxoSmithKline (GSK) Non-prescription Drugs Product Overview
10.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Product Market Performance
10.9.4 GlaxoSmithKline (GSK) Business Overview
10.9.5 GlaxoSmithKline (GSK) Recent Developments
10.10 Amgen
10.10.1 Amgen Non-prescription Drugs Basic Information
10.10.2 Amgen Non-prescription Drugs Product Overview
10.10.3 Amgen Non-prescription Drugs Product Market Performance
10.10.4 Amgen Business Overview
10.10.5 Amgen Recent Developments
10.11 AstraZeneca
10.11.1 AstraZeneca Non-prescription Drugs Basic Information
10.11.2 AstraZeneca Non-prescription Drugs Product Overview
10.11.3 AstraZeneca Non-prescription Drugs Product Market Performance
10.11.4 AstraZeneca Business Overview
10.11.5 AstraZeneca Recent Developments
10.12 Bristol-Myers Squibb
10.12.1 Bristol-Myers Squibb Non-prescription Drugs Basic Information
10.12.2 Bristol-Myers Squibb Non-prescription Drugs Product Overview
10.12.3 Bristol-Myers Squibb Non-prescription Drugs Product Market Performance
10.12.4 Bristol-Myers Squibb Business Overview
10.12.5 Bristol-Myers Squibb Recent Developments
10.13 Eli Lilly
10.13.1 Eli Lilly Non-prescription Drugs Basic Information
10.13.2 Eli Lilly Non-prescription Drugs Product Overview
10.13.3 Eli Lilly Non-prescription Drugs Product Market Performance
10.13.4 Eli Lilly Business Overview
10.13.5 Eli Lilly Recent Developments
10.14 Teva
10.14.1 Teva Non-prescription Drugs Basic Information
10.14.2 Teva Non-prescription Drugs Product Overview
10.14.3 Teva Non-prescription Drugs Product Market Performance
10.14.4 Teva Business Overview
10.14.5 Teva Recent Developments
10.15 Bayer
10.15.1 Bayer Non-prescription Drugs Basic Information
10.15.2 Bayer Non-prescription Drugs Product Overview
10.15.3 Bayer Non-prescription Drugs Product Market Performance
10.15.4 Bayer Business Overview
10.15.5 Bayer Recent Developments
10.16 Novo Nordisk
10.16.1 Novo Nordisk Non-prescription Drugs Basic Information
10.16.2 Novo Nordisk Non-prescription Drugs Product Overview
10.16.3 Novo Nordisk Non-prescription Drugs Product Market Performance
10.16.4 Novo Nordisk Business Overview
10.16.5 Novo Nordisk Recent Developments
10.17 AbbVie
10.17.1 AbbVie Non-prescription Drugs Basic Information
10.17.2 AbbVie Non-prescription Drugs Product Overview
10.17.3 AbbVie Non-prescription Drugs Product Market Performance
10.17.4 AbbVie Business Overview
10.17.5 AbbVie Recent Developments
10.18 Takeda
10.18.1 Takeda Non-prescription Drugs Basic Information
10.18.2 Takeda Non-prescription Drugs Product Overview
10.18.3 Takeda Non-prescription Drugs Product Market Performance
10.18.4 Takeda Business Overview
10.18.5 Takeda Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Non-prescription Drugs Basic Information
10.19.2 Boehringer Ingelheim Non-prescription Drugs Product Overview
10.19.3 Boehringer Ingelheim Non-prescription Drugs Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Takeda
10.20.1 Takeda Non-prescription Drugs Basic Information
10.20.2 Takeda Non-prescription Drugs Product Overview
10.20.3 Takeda Non-prescription Drugs Product Market Performance
10.20.4 Takeda Business Overview
10.20.5 Takeda Recent Developments
11 NON-PRESCRIPTION DRUGS MARKET FORECAST BY REGION
11.1 Global Non-prescription Drugs Market Size Forecast
11.2 Global Non-prescription Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-prescription Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Non-prescription Drugs Market Size Forecast by Region
11.2.4 South America Non-prescription Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Non-prescription Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Non-prescription Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Non-prescription Drugs by Type (2025-2032)
12.1.2 Global Non-prescription Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Non-prescription Drugs by Type (2025-2032)
12.2 Global Non-prescription Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Non-prescription Drugs Sales (K MT) Forecast by Application
12.2.2 Global Non-prescription Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-prescription Drugs Market Size Comparison by Region (M USD)
Table 5. Global Non-prescription Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Non-prescription Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-prescription Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-prescription Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Drugs as of 2022)
Table 10. Global Market Non-prescription Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-prescription Drugs Sales Sites and Area Served
Table 12. Manufacturers Non-prescription Drugs Product Type
Table 13. Global Non-prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-prescription Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-prescription Drugs Market Challenges
Table 22. Global Non-prescription Drugs Sales by Type (K MT)
Table 23. Global Non-prescription Drugs Market Size by Type (M USD)
Table 24. Global Non-prescription Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Non-prescription Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Non-prescription Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-prescription Drugs Market Size Share by Type (2019-2024)
Table 28. Global Non-prescription Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Non-prescription Drugs Sales (K MT) by Application
Table 30. Global Non-prescription Drugs Market Size by Application
Table 31. Global Non-prescription Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Non-prescription Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Non-prescription Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-prescription Drugs Market Share by Application (2019-2024)
Table 35. Global Non-prescription Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-prescription Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Non-prescription Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Non-prescription Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Non-prescription Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Non-prescription Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Non-prescription Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Non-prescription Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Non-prescription Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Non-prescription Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Non-prescription Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Pfizer Non-prescription Drugs Basic Information
Table 52. Pfizer Non-prescription Drugs Product Overview
Table 53. Pfizer Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Non-prescription Drugs SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Roche Non-prescription Drugs Basic Information
Table 58. Roche Non-prescription Drugs Product Overview
Table 59. Roche Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Roche Business Overview
Table 61. Roche Non-prescription Drugs SWOT Analysis
Table 62. Roche Recent Developments
Table 63. Sanofi Non-prescription Drugs Basic Information
Table 64. Sanofi Non-prescription Drugs Product Overview
Table 65. Sanofi Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Non-prescription Drugs SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Johnson and Johnson Non-prescription Drugs Basic Information
Table 70. Johnson and Johnson Non-prescription Drugs Product Overview
Table 71. Johnson and Johnson Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Johnson and Johnson Business Overview
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck and Co. (MSD) Non-prescription Drugs Basic Information
Table 75. Merck and Co. (MSD) Non-prescription Drugs Product Overview
Table 76. Merck and Co. (MSD) Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Merck and Co. (MSD) Business Overview
Table 78. Merck and Co. (MSD) Recent Developments
Table 79. Novartis Non-prescription Drugs Basic Information
Table 80. Novartis Non-prescription Drugs Product Overview
Table 81. Novartis Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. AbbVie Non-prescription Drugs Basic Information
Table 85. AbbVie Non-prescription Drugs Product Overview
Table 86. AbbVie Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. AbbVie Business Overview
Table 88. AbbVie Recent Developments
Table 89. Gilead Sciences Non-prescription Drugs Basic Information
Table 90. Gilead Sciences Non-prescription Drugs Product Overview
Table 91. Gilead Sciences Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. GlaxoSmithKline (GSK) Non-prescription Drugs Basic Information
Table 95. GlaxoSmithKline (GSK) Non-prescription Drugs Product Overview
Table 96. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. GlaxoSmithKline (GSK) Business Overview
Table 98. GlaxoSmithKline (GSK) Recent Developments
Table 99. Amgen Non-prescription Drugs Basic Information
Table 100. Amgen Non-prescription Drugs Product Overview
Table 101. Amgen Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Amgen Business Overview
Table 103. Amgen Recent Developments
Table 104. AstraZeneca Non-prescription Drugs Basic Information
Table 105. AstraZeneca Non-prescription Drugs Product Overview
Table 106. AstraZeneca Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Recent Developments
Table 109. Bristol-Myers Squibb Non-prescription Drugs Basic Information
Table 110. Bristol-Myers Squibb Non-prescription Drugs Product Overview
Table 111. Bristol-Myers Squibb Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Recent Developments
Table 114. Eli Lilly Non-prescription Drugs Basic Information
Table 115. Eli Lilly Non-prescription Drugs Product Overview
Table 116. Eli Lilly Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Recent Developments
Table 119. Teva Non-prescription Drugs Basic Information
Table 120. Teva Non-prescription Drugs Product Overview
Table 121. Teva Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Teva Business Overview
Table 123. Teva Recent Developments
Table 124. Bayer Non-prescription Drugs Basic Information
Table 125. Bayer Non-prescription Drugs Product Overview
Table 126. Bayer Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bayer Business Overview
Table 128. Bayer Recent Developments
Table 129. Novo Nordisk Non-prescription Drugs Basic Information
Table 130. Novo Nordisk Non-prescription Drugs Product Overview
Table 131. Novo Nordisk Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Novo Nordisk Business Overview
Table 133. Novo Nordisk Recent Developments
Table 134. AbbVie Non-prescription Drugs Basic Information
Table 135. AbbVie Non-prescription Drugs Product Overview
Table 136. AbbVie Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. AbbVie Business Overview
Table 138. AbbVie Recent Developments
Table 139. Takeda Non-prescription Drugs Basic Information
Table 140. Takeda Non-prescription Drugs Product Overview
Table 141. Takeda Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Takeda Business Overview
Table 143. Takeda Recent Developments
Table 144. Boehringer Ingelheim Non-prescription Drugs Basic Information
Table 145. Boehringer Ingelheim Non-prescription Drugs Product Overview
Table 146. Boehringer Ingelheim Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Recent Developments
Table 149. Takeda Non-prescription Drugs Basic Information
Table 150. Takeda Non-prescription Drugs Product Overview
Table 151. Takeda Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Takeda Business Overview
Table 153. Takeda Recent Developments
Table 154. Global Non-prescription Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Non-prescription Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Non-prescription Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Non-prescription Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Non-prescription Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Non-prescription Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Non-prescription Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Non-prescription Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Non-prescription Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Non-prescription Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Non-prescription Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Non-prescription Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Non-prescription Drugs Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-prescription Drugs Market Size Comparison by Region (M USD)
Table 5. Global Non-prescription Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Non-prescription Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-prescription Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-prescription Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-prescription Drugs as of 2022)
Table 10. Global Market Non-prescription Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-prescription Drugs Sales Sites and Area Served
Table 12. Manufacturers Non-prescription Drugs Product Type
Table 13. Global Non-prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-prescription Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-prescription Drugs Market Challenges
Table 22. Global Non-prescription Drugs Sales by Type (K MT)
Table 23. Global Non-prescription Drugs Market Size by Type (M USD)
Table 24. Global Non-prescription Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Non-prescription Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Non-prescription Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-prescription Drugs Market Size Share by Type (2019-2024)
Table 28. Global Non-prescription Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Non-prescription Drugs Sales (K MT) by Application
Table 30. Global Non-prescription Drugs Market Size by Application
Table 31. Global Non-prescription Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Non-prescription Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Non-prescription Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-prescription Drugs Market Share by Application (2019-2024)
Table 35. Global Non-prescription Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-prescription Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Non-prescription Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Non-prescription Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Non-prescription Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Non-prescription Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Non-prescription Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Non-prescription Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Non-prescription Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Non-prescription Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Non-prescription Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Non-prescription Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Pfizer Non-prescription Drugs Basic Information
Table 52. Pfizer Non-prescription Drugs Product Overview
Table 53. Pfizer Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Pfizer Business Overview
Table 55. Pfizer Non-prescription Drugs SWOT Analysis
Table 56. Pfizer Recent Developments
Table 57. Roche Non-prescription Drugs Basic Information
Table 58. Roche Non-prescription Drugs Product Overview
Table 59. Roche Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Roche Business Overview
Table 61. Roche Non-prescription Drugs SWOT Analysis
Table 62. Roche Recent Developments
Table 63. Sanofi Non-prescription Drugs Basic Information
Table 64. Sanofi Non-prescription Drugs Product Overview
Table 65. Sanofi Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Non-prescription Drugs SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Johnson and Johnson Non-prescription Drugs Basic Information
Table 70. Johnson and Johnson Non-prescription Drugs Product Overview
Table 71. Johnson and Johnson Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Johnson and Johnson Business Overview
Table 73. Johnson and Johnson Recent Developments
Table 74. Merck and Co. (MSD) Non-prescription Drugs Basic Information
Table 75. Merck and Co. (MSD) Non-prescription Drugs Product Overview
Table 76. Merck and Co. (MSD) Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Merck and Co. (MSD) Business Overview
Table 78. Merck and Co. (MSD) Recent Developments
Table 79. Novartis Non-prescription Drugs Basic Information
Table 80. Novartis Non-prescription Drugs Product Overview
Table 81. Novartis Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Novartis Business Overview
Table 83. Novartis Recent Developments
Table 84. AbbVie Non-prescription Drugs Basic Information
Table 85. AbbVie Non-prescription Drugs Product Overview
Table 86. AbbVie Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. AbbVie Business Overview
Table 88. AbbVie Recent Developments
Table 89. Gilead Sciences Non-prescription Drugs Basic Information
Table 90. Gilead Sciences Non-prescription Drugs Product Overview
Table 91. Gilead Sciences Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. GlaxoSmithKline (GSK) Non-prescription Drugs Basic Information
Table 95. GlaxoSmithKline (GSK) Non-prescription Drugs Product Overview
Table 96. GlaxoSmithKline (GSK) Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. GlaxoSmithKline (GSK) Business Overview
Table 98. GlaxoSmithKline (GSK) Recent Developments
Table 99. Amgen Non-prescription Drugs Basic Information
Table 100. Amgen Non-prescription Drugs Product Overview
Table 101. Amgen Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Amgen Business Overview
Table 103. Amgen Recent Developments
Table 104. AstraZeneca Non-prescription Drugs Basic Information
Table 105. AstraZeneca Non-prescription Drugs Product Overview
Table 106. AstraZeneca Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Recent Developments
Table 109. Bristol-Myers Squibb Non-prescription Drugs Basic Information
Table 110. Bristol-Myers Squibb Non-prescription Drugs Product Overview
Table 111. Bristol-Myers Squibb Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Bristol-Myers Squibb Business Overview
Table 113. Bristol-Myers Squibb Recent Developments
Table 114. Eli Lilly Non-prescription Drugs Basic Information
Table 115. Eli Lilly Non-prescription Drugs Product Overview
Table 116. Eli Lilly Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Eli Lilly Business Overview
Table 118. Eli Lilly Recent Developments
Table 119. Teva Non-prescription Drugs Basic Information
Table 120. Teva Non-prescription Drugs Product Overview
Table 121. Teva Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Teva Business Overview
Table 123. Teva Recent Developments
Table 124. Bayer Non-prescription Drugs Basic Information
Table 125. Bayer Non-prescription Drugs Product Overview
Table 126. Bayer Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bayer Business Overview
Table 128. Bayer Recent Developments
Table 129. Novo Nordisk Non-prescription Drugs Basic Information
Table 130. Novo Nordisk Non-prescription Drugs Product Overview
Table 131. Novo Nordisk Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Novo Nordisk Business Overview
Table 133. Novo Nordisk Recent Developments
Table 134. AbbVie Non-prescription Drugs Basic Information
Table 135. AbbVie Non-prescription Drugs Product Overview
Table 136. AbbVie Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. AbbVie Business Overview
Table 138. AbbVie Recent Developments
Table 139. Takeda Non-prescription Drugs Basic Information
Table 140. Takeda Non-prescription Drugs Product Overview
Table 141. Takeda Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Takeda Business Overview
Table 143. Takeda Recent Developments
Table 144. Boehringer Ingelheim Non-prescription Drugs Basic Information
Table 145. Boehringer Ingelheim Non-prescription Drugs Product Overview
Table 146. Boehringer Ingelheim Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Boehringer Ingelheim Business Overview
Table 148. Boehringer Ingelheim Recent Developments
Table 149. Takeda Non-prescription Drugs Basic Information
Table 150. Takeda Non-prescription Drugs Product Overview
Table 151. Takeda Non-prescription Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Takeda Business Overview
Table 153. Takeda Recent Developments
Table 154. Global Non-prescription Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Non-prescription Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Non-prescription Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Non-prescription Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Non-prescription Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Non-prescription Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Non-prescription Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Non-prescription Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Non-prescription Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Non-prescription Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Non-prescription Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Non-prescription Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Non-prescription Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Non-prescription Drugs Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non-prescription Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-prescription Drugs Market Size (M USD), 2019-2032
Figure 5. Global Non-prescription Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Non-prescription Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-prescription Drugs Market Size by Country (M USD)
Figure 11. Non-prescription Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Non-prescription Drugs Revenue Share by Manufacturers in 2023
Figure 13. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-prescription Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-prescription Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-prescription Drugs Market Share by Type
Figure 18. Sales Market Share of Non-prescription Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Non-prescription Drugs by Type in 2023
Figure 20. Market Size Share of Non-prescription Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Non-prescription Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-prescription Drugs Market Share by Application
Figure 24. Global Non-prescription Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Non-prescription Drugs Sales Market Share by Application in 2023
Figure 26. Global Non-prescription Drugs Market Share by Application (2019-2024)
Figure 27. Global Non-prescription Drugs Market Share by Application in 2023
Figure 28. Global Non-prescription Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-prescription Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Non-prescription Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Non-prescription Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Non-prescription Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Non-prescription Drugs Sales Market Share by Country in 2023
Figure 37. Germany Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Non-prescription Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Non-prescription Drugs Sales Market Share by Region in 2023
Figure 44. China Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Non-prescription Drugs Sales and Growth Rate (K MT)
Figure 50. South America Non-prescription Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Non-prescription Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Non-prescription Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Non-prescription Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Non-prescription Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Non-prescription Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Non-prescription Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Non-prescription Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Non-prescription Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Non-prescription Drugs Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Non-prescription Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-prescription Drugs Market Size (M USD), 2019-2032
Figure 5. Global Non-prescription Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Non-prescription Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-prescription Drugs Market Size by Country (M USD)
Figure 11. Non-prescription Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Non-prescription Drugs Revenue Share by Manufacturers in 2023
Figure 13. Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-prescription Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-prescription Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-prescription Drugs Market Share by Type
Figure 18. Sales Market Share of Non-prescription Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Non-prescription Drugs by Type in 2023
Figure 20. Market Size Share of Non-prescription Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Non-prescription Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-prescription Drugs Market Share by Application
Figure 24. Global Non-prescription Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Non-prescription Drugs Sales Market Share by Application in 2023
Figure 26. Global Non-prescription Drugs Market Share by Application (2019-2024)
Figure 27. Global Non-prescription Drugs Market Share by Application in 2023
Figure 28. Global Non-prescription Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-prescription Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Non-prescription Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Non-prescription Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Non-prescription Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Non-prescription Drugs Sales Market Share by Country in 2023
Figure 37. Germany Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Non-prescription Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Non-prescription Drugs Sales Market Share by Region in 2023
Figure 44. China Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Non-prescription Drugs Sales and Growth Rate (K MT)
Figure 50. South America Non-prescription Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Non-prescription Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Non-prescription Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Non-prescription Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Non-prescription Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Non-prescription Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Non-prescription Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Non-prescription Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Non-prescription Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Non-prescription Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Non-prescription Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Non-prescription Drugs Market Share Forecast by Application (2025-2032)
